JF
Jump Financial Portfolio holdings
AUM
$8.14B
1-Year Return
18.67%
This Quarter Return
+11.86%
1 Year Return
+18.67%
3 Year Return
+54.31%
5 Year Return
+107.56%
10 Year Return
–
AUM
$498M
AUM Growth
–
Cap. Flow
+$498M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
17.34%
Holding
735
New
735
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$35.1M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$19.8M |
| 3 |
CME Group
CME
|
+$5.55M |
| 4 |
Intercontinental Exchange
ICE
|
+$4.5M |
| 5 |
Cboe Global Markets
CBOE
|
+$4.02M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Discretionary | 13.65% |
| 2 | Technology | 13.12% |
| 3 | Healthcare | 10.36% |
| 4 | Financials | 9.55% |
| 5 | Industrials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Dick's Sporting Goods
DKS
$17.9B
| $464K | 0.09% |
+8,022
| New | +$464K |
|
|
RVNC
352
DELISTED
Revance Therapeutics, Inc.
RVNC
| $462K | 0.09% |
+18,365
| New | +$462K |
|
353
Axalta
AXTA
$7.01B
| $458K | 0.09% |
+20,649
| New | +$458K |
|
|
PXD
354
DELISTED
Pioneer Natural Resource Co.
PXD
| $457K | 0.09% |
+5,309
| New | +$457K |
|
355
AB InBev
BUD
$116B
| $455K | 0.09% |
+8,446
| New | +$455K |
|
356
Neurocrine Biosciences
NBIX
$14.3B
| $455K | 0.09% |
+4,725
| New | +$455K |
|
357
Qorvo
QRVO
$8.53B
| $454K | 0.09% |
+3,519
| New | +$454K |
|
358
Chubb
CB
$111B
| $453K | 0.09% |
+3,900
| New | +$453K |
|
359
Sony
SONY
$172B
| $453K | 0.09% |
+29,540
| New | +$453K |
|
360
Centene
CNC
$15.3B
| $449K | 0.09% |
+7,700
| New | +$449K |
|
361
BioXcel Therapeutics
BTAI
$52.1M
| $448K | 0.09% |
+645
| New | +$448K |
|
362
Check Point Software Technologies
CHKP
$21.1B
| $448K | 0.09% |
+3,716
| New | +$448K |
|
363
Liberty Global Class C
LBTYK
$4.04B
| $447K | 0.09% |
+21,770
| New | +$447K |
|
364
Integer Holdings
ITGR
$3.72B
| $446K | 0.09% |
+7,572
| New | +$446K |
|
365
Murphy Oil
MUR
$3.61B
| $445K | 0.09% |
+49,900
| New | +$445K |
|
366
Cincinnati Financial
CINF
$24B
| $444K | 0.09% |
+5,697
| New | +$444K |
|
367
Humana
HUM
$32.8B
| $442K | 0.09% |
+1,068
| New | +$442K |
|
368
Personalis
PSNL
$472M
| $441K | 0.09% |
+20,365
| New | +$441K |
|
369
Genuine Parts
GPC
$19.5B
| $440K | 0.09% |
+4,626
| New | +$440K |
|
370
Alto Ingredients
ALTO
$88.2M
| $439K | 0.09% |
+60,015
| New | +$439K |
|
371
BridgeBio Pharma
BBIO
$10.4B
| $439K | 0.09% |
+11,688
| New | +$439K |
|
372
Bilibili
BILI
$9.96B
| $438K | 0.09% |
+10,545
| New | +$438K |
|
373
W.P. Carey
WPC
$14.7B
| $436K | 0.09% |
+6,840
| New | +$436K |
|
374
Adverum Biotechnologies
ADVM
$74.3M
| $434K | 0.09% |
+4,222
| New | +$434K |
|
375
Emergent Biosolutions
EBS
$403M
| $434K | 0.09% |
+4,200
| New | +$434K |
|